CD8A and cancer: Further validation of this model across a broader spectrum of cancer types is warranted, while integrating ST data of ccRCC to assess the spatial distribution of iCAFs in relation to immune cell infiltration, particularly CD8+ T cells, is also demanded in ccRCC‐specific research.